Atom Bioscience reports positive Phase IIa chronic gout therapy trial data

Atom Bioscience reports positive Phase IIa chronic gout therapy trial data

Submitted by admin on March 2, 2023 - 9:56am
Source: 
Clinical Trials Arena
News Tags: 
Atom Bioscience
gout
clinical trials
ABP-671
Headline: 
Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
snippet: 

At ABP-671 1mg doses given once daily, 86% of the subjects reached serum uric acid levels that were below 6mg/dL.

Do Not Allow Advertisers to Use My Personal information